ProGnosis Biotech Against COVID-19 (Part 2)

ProGnosis-Biotech-COVID-19

Share This Post

Share on twitter
Share on linkedin
Share on facebook
Share on email

As the pandemic progresses, we would like to announce our contribution to this battle:

Three recently developed ELISA test kits for the detection of COVID-19 antibodies.

  • Bio-Shield 2019-nCoV IgG
  • Bio-Shield 2019-nCoV IgM
  • Bio-Shield 2019-nCoV Total Immunoglobulins (IgA, IgG, IgM)

ELISA is a highly reliable technique, used around the world for mass screening virus infections in the blood. It is considered to be a simple laboratory method, it can be automated, and the result is obtained in less than 2 hours.

The Bio-Shield 2019-nCoV ELISA kits are optimized for maximum specificity and sensitivity, as there are scientific publications pointing out that some patients develop very low levels of immunoglobulins.

The above products will be available for orders within the next 10 days.

Next in line, will be the announcement of the Lateral Flow Rapid test nCoV series.

More To Explore

Rapid-Test-Ag_Self-Test_3

Authorization for Rapid AG Self-Test

The Rapid Test Ag 2019-nCoV (Self-Test) has been granted a special authorization from the National Organization for Medicines (EOF) for use in Greece, with Ref